SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-009614
Filing Date
2024-06-28
Accepted
2024-06-28 16:15:49
Documents
13
Period of Report
2024-06-26
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K ymab-20240626x8k.htm   iXBRL 8-K 37033
  Complete submission text file 0001558370-24-009614.txt   158397

Data Files

Seq Description Document Type Size
2 EX-101.SCH ymab-20240626.xsd EX-101.SCH 3399
3 EX-101.LAB ymab-20240626_lab.xml EX-101.LAB 15926
4 EX-101.PRE ymab-20240626_pre.xml EX-101.PRE 10318
16 EXTRACTED XBRL INSTANCE DOCUMENT ymab-20240626x8k_htm.xml XML 4845
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 241085956
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)